By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


Start Up

Company News
Regulus Therapeutics, Inc. Receives Orphan Drug Designation For RG-012, A microRNA Therapeutic For The Treatment Of Alport Syndrome 7/21/2014 12:17:12 PM
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014 6:44:51 AM
Regulus Therapeutics, Inc. Appoints Paul C. Grint, M.D. As Chief Medical Officer 6/16/2014 8:06:08 AM
Regulus Therapeutics, Inc. To Present At The Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference 5/12/2014 6:15:55 AM
Regulus Therapeutics, Inc. Reports First Quarter 2014 Financial Results And Recent Highlights 5/9/2014 6:47:22 AM
Regulus Therapeutics, Inc. Announces Timing For First Quarter 2014 Financial Results Webcast And Conference Call 5/2/2014 8:42:55 AM
Regulus Therapeutics, Inc. To Present At The Deutsche Bank (DB) 39th Annual Healthcare Conference 5/1/2014 7:46:37 AM
Regulus Therapeutics, Inc. Presents Positive Preclinical Data On miR-21 And miR-221 Oncology Programs In Oral And Poster Presentations At American Association for Cancer Research 2014 Annual Meeting 4/7/2014 7:20:45 AM
Regulus Therapeutics, Inc. To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 6:32:27 AM
Regulus Therapeutics, Inc. Commences Dosing RG-101 In Healthy Volunteers In Phase I Study 3/5/2014 10:39:10 AM